Role of raloxifene in the management of postmenopausal osteoporosis of rheumatoid arthritis patients

Due to the severe side effects of long-term treatment using hormone replacement therapy, Raloxifene (RLX) is introduced with beneficial effects on rheumatoid arthritis (RA) for postmenopausal women. This review was conducted to collect data from the available literature on RLX for the management of...

Full description

Bibliographic Details

Published in:	European Pharmaceutical Journal
Main Authors:	Salari M., Sahebary M., Sarafraz M., Asadi Sakhmarresi T.
Format:	Article
Language:	English
Published:	Sciendo 2023-09-01
Subjects:	autoimmunity raloxifene rheumatoid arthritis osteoporosis postmenopausal
Online Access:	https://doi.org/10.2478/afpuc-2023-0003